Adverse Reactions Biosimilars Specialty Pharmacies 
Pharmacy Times
JULY 25, 2025
Common adverse reactions in pediatric patients included viral infections, nasopharyngitis, and cough, but the drug was generally well-tolerated. In pediatric patients with persistent or chronic ITP, the most common adverse reactions (10% or more) included viral infection, nasopharyngitis, cough, pyrexia, and oropharyngeal pain.
Pharmacy Times
JULY 22, 2025
Early identification of genetic markers associated with treatment efficacy or adverse reactions helps reduce late-stage clinical trial failures and improves the overall efficiency of the development pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 2, 2025
Common adverse reactions included gastrointestinal issues, with a low discontinuation rate due to adverse drug reactions. OLC, a lanthanum-based phosphate binder, showed efficacy and tolerability in a phase 2 trial, with most patients achieving target serum phosphate levels.
Pharmacy Times
JUNE 12, 2025
3 The safety profile was favorable with the most common adverse effect (AE) being increased creatinine, increased potassium, dysuria, decreased hemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, increased eosinophils, decreased lymphocytes, urinary tract infection, decreased neutrophils, and hematuria.
Pharmacy Times
JULY 9, 2025
While no new adverse reactions were observed in this study, higher rates of hypersensitivity and infusion-related reactions were observed.
Pharmacy Times
JULY 18, 2025
1,2 The most common adverse reactions are abdominal pain, diarrhea, dizziness, flatulence, headache, nausea, soft feces, vomiting, and vulvovaginal candidiasis. The use of gepotidacin in pregnancy and breastfeeding has not been evaluated. It has not been studied in patients younger than 12 years or who weigh less than 40 kg.
Expert insights. Personalized for you.
26 
Let's personalize your content